Cargando…
Spironolactone as an Adjunctive Treatment in Neovascular Age-Related Macular Degeneration
Neovascular age-related macular degeneration (AMD) is a potentially sight-threatening condition. The current standard-of-care treatment regimen is serial intravitreal antivascular endothelial growth factor injections. While these typically have great success, they do carry exceptional treatment burd...
Autores principales: | Kapoor, Kapil G., Sim, Jennifer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471798/ https://www.ncbi.nlm.nih.gov/pubmed/28626417 http://dx.doi.org/10.1159/000475880 |
Ejemplares similares
-
Mineralocorticoid Antagonists as Adjuncts in Neovascular Age-Related Macular Degeneration
por: Kapoor, Kapil G., et al.
Publicado: (2016) -
Spironolactone for Secondary Central Serous Chorioretinopathy: A Challenge-Rechallenge Case
por: Kapoor, Kapil G., et al.
Publicado: (2017) -
Pachychoroid Neovasculopathy Disguising as Age-Related Macular Degeneration Treated by Spironolactone and Anti-VEGF Combination Therapy
por: Keidel, Leonie F., et al.
Publicado: (2021) -
Simultaneous development of full-thickness macular hole and neovascular age-related macular degeneration
por: Aoki, Shuichiro, et al.
Publicado: (2022) -
Macular Hole Formation Following Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration
por: Ali Said, Yasmin, et al.
Publicado: (2022)